Lynch syndrome screening in patients with young-onset extra-colorectal Lynch syndrome-associated cancers
International Journal of Clinical Oncology · 2024
DOI: 10.1007/s10147-024-02609-w ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Clinical Oncology, 2024. Verfasst von Atsushi Yamada und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Oncology, Kyoto University Hospital, 54 Shogoin-kawahara-cho, Sakyo-ku, Kyoto, Kyoto, 606-8507, Japan. yatsushi@kuhp.kyoto-u.a…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Hereditary Nonpolyposis, DNA Mismatch Repair. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, National Cancer Center Research and Development Funds.
Abstract (Originalsprache)
BACKGROUND: Lynch syndrome (LS) is a hereditary cancer syndrome caused by pathogenic germline variants in mismatch repair (MMR) genes, which predisposes to various types of cancers showing deficient MMR (dMMR). Identification of LS probands is crucial to reduce cancer-related deaths in affected families. Although universal screening is recommended for colorectal and endometrial cancers, and age-restricted screening is proposed as an alternative, LS screening covering a broader spectrum of cancer types is needed. In the current study, we elucidated the rate of dMMR tumors and evaluated the outcome of LS screening in young-onset extra-colorectal LS-associated cancers. METHODS: Immunohistochemistry for MMR proteins were retrospectively performed in a total of 309 tissue samples of endometrial, non-mucinous ovarian, gastric, urothelial, pancreatic, biliary tract, and adrenal cancers in patients < 50 years of age. Clinicopathological information and the results of genetic testing were obtained from medical charts. RESULTS: There were 24 dMMR tumors (7.8%) including 18 endometrial, three ovarian, two urothelial, and one gastric cancer. Co-occurrence of colorectal cancer and family history of LS-associated cancers was significantly enriched in patients with dMMR tumors. Among the 16 patients with dMMR tumors who were informed of the immunohistochemistry results, five with endometrial and one with urothelial cancer were diagnosed as LS with positive pathogenic variants in MMR genes. CONCLUSIONS: We report the outcome of immunohistochemistry for MMR proteins performed in multiple types of young-onset extra-colorectal LS-associated cancers. Our study demonstrates the feasibility of a comprehensive LS screening program incorporating young-onset patients with various types of extra-colorectal LS-associated cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Oncology, Kyoto University Hospital, 54 Shogoin-kawahara-cho, Sakyo-ku, Kyoto, Kyoto, 606-8507, Japan. yatsushi@kuhp.kyoto-u.ac.jp.
- Department of Real World Data Research and Development, Graduate School of Medicine, Kyoto University, 54 Shogoin-kawara-cho, Sakyo-ku, Kyoto, Japan. yatsushi@kuhp.kyoto-u.ac.jp.
- Department of Diagnostic Pathology, Graduate School of Medicine, Kyoto University, 54 Shogoin-kawara-cho, sakyo-ku, Kyoto, Japan.
- Department of Clinical Oncology, Kyoto University Hospital, 54 Shogoin-kawahara-cho, Sakyo-ku, Kyoto, Kyoto, 606-8507, Japan.
- Department of Gynecology and Obstetrics, Graduate School of Medicine, Kyoto University, 54 Shogoin-kawara-cho, sakyo-ku, Kyoto, Japan.
- Division of Hepato-Biliary-Pancreatic Surgery and Transplantation, Department of Surgery, Graduate School of Medicine, Kyoto University, 54 Shogoin-kawara-cho, sakyo-ku, Kyoto, Japan.
Förderung
- Japan Agency for Medical Research and Development
- National Cancer Center Research and Development Funds
Zitieren
APA
Yamada, A., Doi, Y., Minamiguchi, S., Kondo, T., Sunami, T., Horimatsu, T., Hamanishi, J., Mandai, M., Hatano, E., Kobayashi, T., Hisamori, S., Obama, K., Seno, H., Haga, H., Torishima, M., Murakami, H., Nakajima, T., Yamada, T., Kosugi, S., …, & Muto, M. (2024). Lynch syndrome screening in patients with young-onset extra-colorectal Lynch syndrome-associated cancers. International Journal of Clinical Oncology. https://doi.org/10.1007/s10147-024-02609-w
Vancouver
Yamada A, Doi Y, Minamiguchi S, Kondo T, Sunami T, Horimatsu T, et al. Lynch syndrome screening in patients with young-onset extra-colorectal Lynch syndrome-associated cancers. International Journal of Clinical Oncology. 2024. doi:10.1007/s10147-024-02609-w
BibTeX
@article{Yamada2024,
author = {Yamada, Atsushi and Doi, Yukari and Minamiguchi, Sachiko and Kondo, Tomohiro and Sunami, Tomohiko and Horimatsu, Takahiro and Hamanishi, Junzo and Mandai, Masaki and Hatano, Etsuro and Kobayashi, Takashi and Hisamori, Shigeo and Obama, Kazutaka and Seno, Hiroshi and Haga, Hironori and Torishima, Masako and Murakami, Hiromi and Nakajima, Takeshi and Yamada, Takahiro and Kosugi, Shinji and Sugano, Kokichi and Muto, Manabu},
title = {Lynch syndrome screening in patients with young-onset extra-colorectal Lynch syndrome-associated cancers},
journal = {International Journal of Clinical Oncology},
year = {2024},
doi = {10.1007/s10147-024-02609-w}
}
EUVIMED